Fundz

Astrocyte Pharmaceuticals Inc. reported raising $1.36 Million in an initial SEC Form D filing, from an offering of $1.69 Million

PRIVATEApr 07, 2017$1.4M of $1.7M raised

Amount Raised

$1.36 Million

$1.36 Million sold, per SEC Form D (first sale Apr 7, 2017)

Round Type

Seed

GrotonHealthcare

Who else raised in Healthcare around the same time

Companies in the same sectors as Astrocyte Pharmaceuticals Inc. that raised within 45 days of this round, from Fundz verified event records.

  • NarrativeDx Inc. raised $3.7M (Seed) on May 22, 2017.
  • Xeris Biopharma Holdings raised $30M on May 22, 2017.
  • CareCloud, Inc. raised $2.3M (Seed) on May 19, 2017.
  • Thirty Madison raised $2.7M (Seed) on May 19, 2017.
  • Ideal Implant Inc raised $500K (Seed) on May 19, 2017.
  • Bellerophon Therapeutics, Inc. raised $1.6M (Seed) on May 19, 2017.

Who to call at Astrocyte Pharmaceuticals Inc., and when

A new round usually means Astrocyte Pharmaceuticals Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Astrocyte Pharmaceuticals Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Astrocyte Pharmaceuticals Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Astrocyte Pharmaceuticals Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Astrocyte Pharmaceuticals Inc.

Location

93 SHENNECOSSETT ROAD

Groton, Connecticut, United States

About

Astrocyte Pharmaceuticals is a drug discovery and development company dedicated to accelerating the recovery and well-being of brain injury patients. Astrocyte is committed to proving the neuroprotective benefits of enhanced mitochondrial energy production in astrocytes, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke, TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Astrocyte Pharmaceuticals Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsTed L., Vice President of Research hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Astrocyte Pharmaceuticals Inc.'s next move

See what Strategic adds

Astrocyte Pharmaceuticals Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.